SITC Cancer Immunotherapy CONNECT

Browse our other events


2025 Winter School

2025 Cancer Immunotherapy Winter School

February 11–14, 2025 in Austin, TX
and Virtually

Explore the core principles of tumor immunology and cancer immunotherapy, including biomarker technology, validation and clinical integration, clinical trial design, data analysis and considerations for combination therapies.

Register Today
2025 Spring Scientific

2025 Spring Scientific: Cellular Therapy for Solid Tumors

March 12–14, 2025 in San Diego, CA
& Virtually

SITC will bring the brightest minds and the next generation of leaders together to explore promising science and develop novel opportunities to challenges that impede bringing these novel therapies to patients in need.

Register Today


2024 Medlive

Keep Pace with Changes to the NSCLC Immunotherapy Landscape!

Access SITC and Medlive's free CME education on non-small cell lung cancer (NSCLC) led by a panel of thoracic oncologists! Uncover key updates for advanced or metastatic NSCLC & patient-centered treatment strategies for special populations.

Watch Now


2025 Deep Dive

Targets for Cancer IO: A Deep Dive Series 5

SITC is pleased to announce our fifth Targets for Cancer IO: A Deep Dive live webinar series. Expert leaders in their fields will provide an overview of the current state of the science and address questions about its future. An interactive Q&A session will follow the topic overview, providing participants with the opportunity to ask questions.

Register Now


2024 Medlive

SITC Summit on Neuro Immuno-Oncology: From Challenges to Opportunities

Wed., Feb. 19, 2025 - 124 p.m. EDT

This summit will highlight translational and clinical research in neuro immuno-oncology, areas of opportunity and development in the field, and how this novel research will advance the use of immunotherapy to treat brain tumors.

Register Now

Making Cure a Reality

The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven society dedicated to professionals working in the field of cancer immunotherapy.

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

Learn More

 Upcoming SITC Events


 Read the Latest SITC News

JITC Digest January 2025

INSIDE THIS ISSUE: Letter from the Editor | JITC Editor ...
In cooperation with the Food and Drug Administration (FDA), and as a service to our members, ...

Immune Monitor - December 2024

A Message from the President Over the last 12 months, you collectively dedicated your creativity, ...

 Latest Discussions

  • NCI Virtual Workshop - In Vivo Engineering of Immune Cells ( IVEIC ) for Cancer ...

    3 people like this.
  • The abstract submission site is NOW OPEN for 2025 SITC Spring Scientific ...

  • 2024 IOTOX Symposium

    The MD Anderson Internal Medicine Division and Cancer Medicine Division are ...

JITC Logo

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Read the Journal

 Join the SITC Family